Eko

A product shot of the Eko Duo device and connected tablet app
By  Dave Muoio 12:16 pm November 9, 2020
This morning, digital cardiopulmonary health startup Eko pulled back the curtain on $65 million in new funding. The Series C raise was headed by Capital Partners and Questa Capital, and also saw participation from Artis Ventures, DigiTx Partners, NTTVC, 3M Ventures and other investors. WHAT IT DOES Based in Oakland, California, Eko is known for combining ECG-enabled digital stethoscope devices...
By  Dave Muoio 02:29 pm October 22, 2020
Searching for outbreaks. The long and sometimes muddled tradition of predicting outbreak hot spots by analyzing search engine activity has continued into the COVID-19 era, with Mayo Clinic researchers publishing new findings that suggest strong correlations between certain keywords and case reports. In reviewing data from Jan. 22 to April 6, "face mask," "Lysol" and "COVID stimulus check" had the...
By  Laura Lovett 01:40 pm August 4, 2020
Cardio-focused digital health company Eko has inked a deal with AstraZeneca in order for the two to work together to develop digital health-screening tools.  According to the companies, the pharm giant will be looking to employ Eko’s AI-enabled algorithms in developing early detection tools, as well as to use the tech in clinical trials.  WHY IT MATTERS  Heart disease accounts for roughly one in...
By  Laura Lovett 03:53 pm May 14, 2020
Early this week cardiac-focused digital health company Eko scored a temporary Emergency Use Authorization (EUA) for its ECG low ejection fraction tool, which can be used to help clinicians spot cardiac complications associated with the novel coronavirus. Providers are able to use the tool in order to get an assessment of Left Ventricular Ejection Fraction, a measure which providers can use to...
By  Laura Lovett 11:51 am January 28, 2020
This morning digital cardiac health startup Eko announced that its atrial fibrillation and heart murmur detection algorithm landed a 510(k) FDA clearance. The new algorithms are designed to integrate with Eko’s stethoscope, which is already on the market, and be used by healthcare providers.  The company said it plans to add more algorithms in the future. Next up will be an ECG-based algorithm...
By  Dave Muoio 01:40 pm December 19, 2019
ECG algorithm picks up Breakthrough Device status. Eko, the maker of tools for monitoring heart function, announced yesterday that a novel ECG-based algorithm for detecting lowered left ventricular ejection fraction has received Breakthrough Device designation from the FDA. By analyzing a 15-second clip of ECG data collected via the company’s other products, the algorithm aims to assist with...
By  Laura Lovett 03:59 pm November 26, 2019
Eko, the maker of devices and platforms for monitoring heart function, has announced the rollout of a second version of its CORE stethoscope that includes noise canceling capabilities and a sound amplifying feature.  Customers can buy the product as a digital attachment or an assembled stethoscope. The latest version will include a wireless connection to Eko’s software and a 10-hour battery. On...
By  Dave Muoio 04:18 pm November 22, 2019
There are few clinical areas more in need of innovation than heart disease. It’s the leading killer among men and women in the US, accounting for one in every four deaths by the CDC’s numbers, and yet it’s also a body of health conditions that could be substantially mitigated through a number of lifestyle and behavior changes. So of course it’s little surprise that cardiovascular health and care...
By  Dave Muoio 04:07 pm November 19, 2019
Device regulation is a hurdle for any medical tech company, but doubly so for startups hoping to strike it big with their very first digital health product. With limited resources and experience, pushing a device through the FDA’s door and onto the market is a multi-year gauntlet of validation, documentation and, unfortunately, frustration. To help young companies take a bit of the guesswork out...
By  Dave Muoio 12:28 pm September 25, 2019
Eko, maker of devices and platforms for monitoring heart function, has raised $20 million in Series B funding. The raise was led by ARTIS Ventures, and also includes DigiTx Partners, NTT Venture Capital (NTTVC), 3M Ventures, Mayo Clinic, Seaph Group and XTX Ventures. Eko closed its previous rounds in February of last year and early 2015. Today’s announcement brings the company’s lifetime capital...